These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
553 related articles for article (PubMed ID: 31090930)
21. Scope of symptoms and self-management strategies for chemotherapy-induced peripheral neuropathy in breast cancer patients. Speck RM; DeMichele A; Farrar JT; Hennessy S; Mao JJ; Stineman MG; Barg FK Support Care Cancer; 2012 Oct; 20(10):2433-9. PubMed ID: 22231480 [TBL] [Abstract][Full Text] [Related]
22. Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison. Johnson K; Stoffel B; Schwitter M; Hayoz S; Rojas Mora A; Fischer Maranta A; El Saadany T; Hasler U; von Moos R; Patzen A; Mark M; Roberts G; Cathomas R Support Care Cancer; 2024 Jul; 32(8):554. PubMed ID: 39066890 [TBL] [Abstract][Full Text] [Related]
23. Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study. Watanabe T; Kuranami M; Inoue K; Masuda N; Aogi K; Ohno S; Iwata H; Mukai H; Uemura Y; Ohashi Y Cancer; 2017 Mar; 123(5):759-768. PubMed ID: 28081304 [TBL] [Abstract][Full Text] [Related]
24. Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy. Adra J; Giglio D; Karlsson P; Zetterberg H; Einbeigi Z Acta Oncol; 2024 Aug; 63():636-641. PubMed ID: 39099324 [TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-Induced Peripheral Neuropathy in Egyptian Patients: Single Institution Retrospective Analysis. Gaballah A; Shafik A; Elhusseiny K; Ashraf M Asian Pac J Cancer Prev; 2018 Aug; 19(8):2223-2227. PubMed ID: 30139229 [TBL] [Abstract][Full Text] [Related]
26. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363 [TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-induced peripheral neuropathy-patient-reported outcomes compared with NCI-CTCAE grade. Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D Support Care Cancer; 2019 Dec; 27(12):4771-4777. PubMed ID: 30972648 [TBL] [Abstract][Full Text] [Related]
28. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial. Hanai A; Ishiguro H; Sozu T; Tsuda M; Yano I; Nakagawa T; Imai S; Hamabe Y; Toi M; Arai H; Tsuboyama T J Natl Cancer Inst; 2018 Feb; 110(2):141-148. PubMed ID: 29924336 [TBL] [Abstract][Full Text] [Related]
29. A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52). von Minckwitz G; Conrad B; Reimer T; Decker T; Eidtmann H; Eiermann W; Hackmann J; Möbus V; Marmé F; Potenberg J; Stickeler E; Simon E; Thomssen C; Huober J; Denkert C; Alfer J; Jackisch C; Nekljudova V; Burchardi N; Loibl S; Cancer; 2015 Oct; 121(20):3639-48. PubMed ID: 26111104 [TBL] [Abstract][Full Text] [Related]
30. The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice. Simon NB; Danso MA; Alberico TA; Basch E; Bennett AV Qual Life Res; 2017 Oct; 26(10):2763-2772. PubMed ID: 28664460 [TBL] [Abstract][Full Text] [Related]
31. Chemotherapy-induced peripheral neuropathy in newly diagnosed breast cancer survivors treated with taxane: a prospective longitudinal study. Wang YJ; Chan YN; Jheng YW; Wu CJ; Lin MW; Tseng LM; Tsai YF; Liu LC Support Care Cancer; 2021 Jun; 29(6):2959-2971. PubMed ID: 33025227 [TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study. Pereira S; Fontes F; Sonin T; Dias T; Fragoso M; Castro-Lopes JM; Lunet N Support Care Cancer; 2016 Apr; 24(4):1571-81. PubMed ID: 26384827 [TBL] [Abstract][Full Text] [Related]
33. High-dose paclitaxel in combination with doxorubicin, cyclophosphamide and peripheral blood progenitor cell rescue in patients with high-risk primary and responding metastatic breast carcinoma: toxicity profile, relationship to paclitaxel pharmacokinetics and short-term outcome. Somlo G; Doroshow JH; Synold T; Longmate J; Reardon D; Chow W; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Shibata SI; Tetef ML; Yen Y; Kogut N; Schriber J; Alvarnas J Br J Cancer; 2001 Jun; 84(12):1591-8. PubMed ID: 11401310 [TBL] [Abstract][Full Text] [Related]
34. Improvement of paclitaxel-induced neuropathy by substitution of docetaxel for paclitaxel. Rose PG; Smrekar M Gynecol Oncol; 2003 Nov; 91(2):423-5. PubMed ID: 14599877 [TBL] [Abstract][Full Text] [Related]
35. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164 [TBL] [Abstract][Full Text] [Related]
36. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58. Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of anemia, neutropenia and skin toxicities in standard or dose-dense doxorubicin/cyclophosphamide (AC)-paclitaxel or docetaxel adjuvant chemotherapy in breast cancer. Schwartz J; Domchek SM; Hwang WT; Fox K Ann Oncol; 2005 Feb; 16(2):247-52. PubMed ID: 15668278 [TBL] [Abstract][Full Text] [Related]
38. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer. Schneider BP; Zhao F; Ballinger TJ; Garcia SF; Shen F; Virani S; Cella D; Bales C; Jiang G; Hayes L; Miller N; Srinivasiah J; Stringer-Reasor EM; Chitalia A; Davis AA; Makower DF; Incorvati J; Simon MA; Mitchell EP; DeMichele A; Miller KD; Sparano JA; Wagner LI; Wolff AC J Clin Oncol; 2024 Aug; 42(24):2899-2907. PubMed ID: 38828938 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritoneal cancer: study protocol for a phase III, double-blind, randomized study. Park SJ; Yim GW; Paik H; Lee N; Lee S; Lee M; Kim HS J Gynecol Oncol; 2021 Sep; 32(5):e73. PubMed ID: 34132071 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant regimens with trastuzumab administered for small HER2-positive breast cancer in routine clinical practice. Antolín-Novoa S; Blanco-Campanario E; Antón A; Gallegos-Sancho MI; Pérez-Carrión R; Peláez I; Galán-Brotons A; de la Cruz-Merino L; Murías-Rosales A; Clin Transl Oncol; 2015 Nov; 17(11):862-9. PubMed ID: 26103952 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]